About FDA

Frequently Used Guidance Documents

ODEIII specific guidances

Regulatory guidances

 Electronic Submissions Guidances

Safety Guidances

Labeling Guidances

Other, specific therapeutics, products Guidances


Return to the Office of Drug Evaluation III (ODEIII) page



Page Last Updated: 12/17/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English